Zleep Hotels in Denmark rebrands to Four Points Flex by Sheraton, enhancing its international appeal and offering access to Marriott Bonvoy's loyalty program.

Novo Nordisk’s amycretin shows 22% weight loss over 36 weeks, potentially surpassing Eli Lilly’s Zepbound. Further trials are planned.

One of Novo Nordisk's next-generation obesity shots to follow up on the success of Wegovy helped patients lose 22% of their weight in 36 weeks, according to early-stage trial results on Friday, boosting the drugmaker's shares.

One of Novo Nordisk's next-generation obesity shots to follow up on its success with Wegovy helped patients lose 22% of their weight in 36 weeks, according to early-stage trial results on Friday, boosting the drugmaker's shares.

Novo Nordisk today announced topline results from a phase 1b/2a clinical trial with amycretin, a unimolecular GLP-1 and amylin receptor agonist intended for once weekly

Automatic bids to the College Football Playoff in 2024 equated to automatic losses. Following the conclusion of the quarterfinal round of the initial 12-team playoff, all four of the teams that ...

Kennedy once again betrays his ignorance about Medicaid. “The premiums are too high, the deductibles are too high, and everybody’s getting sicker,” he said. But Medicaid has no premiums or ...

The company has so far only launched Wegovy in the U.S., Britain, Germany, Norway, and its home market Denmark. Wegovy is the first-to-market in a new class of highly effective weight-loss drugs.

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

It came after Denmark said on Monday it plans to spend $2.05 billion to boost its military presence in the Arctic. While the Scandinavian country is responsible for Greenland's security and ...

By Kenneth P. Vogel Reporting from Washington The government of Denmark has not historically been a big spender on Washington lobbying. But days before President Trump took office for a second ...